Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular lithotripsy (IVL) platform developer ...

Boston Scientific (BSX) announced on Wednesday the acquisition of the ~74% stake in Bolt Medical that the medical devices ...

Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Bolt Medical, the developer of an intravascular ...

Boston Scientific has agreed to acquire the rest of Bolt Medical, the developer of an intravascular-lithotripsy, or IVL, laser-based platform for the treatment of coronary and peripheral artery ...

Boston Scientific initially developed the concept for the Bolt IVL system, which is engineered to fracture calcium using ...

Marlborough-based Boston Scientific has entered into a definitive agreement to acquire California-based medical equipment ...

Boston Scientific Corp. is paying $443 million upfront, plus up to $221 million in possible milestones, to buy the remainder ...

The deal for Bolt, developer of an intravascular lithotripsy system to treat coronary and peripheral artery disease, ...

In this article, we are going to take a look at where Boston Scientific Corp. (NYSE ... Medical is focused on the design and development of laser-based IVL catheters used in coronary and ...

Boston Scientific Corp. is paying $443 million up ... Bolt announced it had completed two trials of its intravascular lithotripsy (IVL) laser-based catheter that would be used to seek approval ...